× ×ª×× × ×ª×¨×פ×
××רש×
| ××× ×× ×× × ×ספ××
|
|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
L01XG
Proteasome inhibitors
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
ת××-×ר××× - I.V
|
| צ×רת ××× ××
|
×××§× ×××× ×ª ת×××¡× ××ר×ק×, POWDER FOR SOLUTION FOR INJECTION
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation
|
| × ×ª×× × ×ס×
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| ××××××× × ×¤××¦× - ×סרת ××××××ת ×¢× ×ס×רת ×××××× ×ס×
|
23/01/2011
|
×××××××××
|
BORTEZOMIB
|
××××××× × ×¤×צ×, multiple myeloma
|
×¦× ××××× ×ר×××ת ×××××ª× (תר×פ×ת ××¡× ×©×ר××ª× ××ר×××ת) סע××£ 2× (30)
|
| ××××××× × ×¤××¦× - ××פ×× ×ש×××× ×¢× Thalidomide
|
03/01/2010
|
×××××××××
|
BORTEZOMIB
|
××××××× × ×¤×צ×, multiple myeloma
|
×¦× ××××× ×ר×××ת ×××××ª× (תר×פ×ת ××¡× ×©×ר××ª× ××ר×××ת) סע××£ 2× (30)
|
| ×××פ××× ×ס×× Mantle cell - ××פ×× ×תק××
|
03/01/2010
|
×××××××××
|
BORTEZOMIB
|
mantle cell lymphoma, ×××פ××× ×ס×× mantle cell, MCL
|
×¦× ××××× ×ר×××ת ×××××ª× (תר×פ×ת ××¡× ×©×ר××ª× ××ר×××ת) סע××£ 2× (30)
|
××××××× × ×¤××¦× - ×§× ××פ×× ×¨×ש×× ×××××× ×ס××××× ×××× ××××:Â
- ×××× ×ר××ת ×פ×ש×ת
- ×× ×¡×¤×קת ××××ת
- plasma cell leukemia.
|
01/01/2009
|
×××××××××
|
BORTEZOMIB
|
××××××× × ×¤×צ×, multiple myeloma
|
×¦× ××××× ×ר×××ת ×××××ª× (תר×פ×ת ××¡× ×©×ר××ª× ××ר×××ת) סע××£ 2× (30)
|
| ××××××× × ×¤××¦× - ×§× ××פ×× ×©× × ×× ×©××ש×
|
01/07/2006
|
×××××××××
|
BORTEZOMIB
|
××××××× × ×¤×צ×, multiple myeloma
|
×¦× ××××× ×ר×××ת ×××××ª× (תר×פ×ת ××¡× ×©×ר××ª× ××ר×××ת) סע××£ 2× (30)
|
|
| ש×××ש ×ס×
|
ת×ר×× ××××× ×ס×
- 01/07/2006
|
×ס×רת ××××× ×ס×
- ×. ×תר××¤× ×ª×× ×ª× ×××פ×× ××קר×× ××××:
- 1. ××××××× × ×¤×צ×, ×¢×××× ×× ×תק××ת ×××ר ××פ×× ×§××× ××× ×פ××ת ××× ××§× ××פ××× ×¨×ש××. ×××× ×××× ×××× ×××פ×× ×תר××¤× ×× ×× ××××ª× × ×©× ×ª× ×××ר ××פ×× ×§××× ×תר××¤× ××.
- 2. ×××פ××× ×ס×× Mantle cell ×¢××ר ××××× ×©××××ª× ×××¨× (relapsed) ×××ר ××פ×× ×§××× ××× ×פ××ת.
- ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ×××× ×§×××××× ×× ×¨××¤× ××××× ××××××××××.
|
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
××× ×¢××× ×ר×פ×
Â
|
ת×ר×× ×¢××××: 04/02/2022
TEVA
××ר×××××× - Bortezomib
true
השינוי האחרון נעשה בֹ־22 ביוני 2025 ב־01:52
